CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment.
about
Critical role of activating transcription factor 4 in the anabolic actions of parathyroid hormone in bonePDE8 regulates rapid Teff cell adhesion and proliferation independent of ICER.Hyperlipidemia impairs osteoanabolic effects of PTH.Nmp4/CIZ suppresses parathyroid hormone-induced increases in trabecular bone.Ligand-mediated activation of an engineered gs g protein-coupled receptor in osteoblasts increases trabecular bone formationCalcitonin induces expression of the inducible cAMP early repressor in osteoclasts.Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation.Suppression of autophagy by FIP200 deletion leads to osteopenia in mice through the inhibition of osteoblast terminal differentiation.Anabolic and catabolic regimens of human parathyroid hormone 1-34 elicit bone- and envelope-specific attenuation of skeletal effects in Sost-deficient mice.Neural Crest-Specific TSC1 Deletion in Mice Leads to Sclerotic Craniofacial Bone LesionMolecular and cellular mechanisms of the anabolic effect of intermittent PTHOsteopenia in transgenic mice with osteoblast-targeted expression of the inducible cAMP early repressor.Genetic deletion of catalytic subunits of AMP-activated protein kinase increases osteoclasts and reduces bone mass in young adult mice.Investigational parathyroid hormone receptor analogs for the treatment of osteoporosis.Regulatory T-cells and cAMP suppress effector T-cells independently of PKA-CREM/ICER: a potential role for Epac.
P2860
Q27338722-A0E19038-3B64-4482-B411-FFA93785074CQ30987183-CBE32B0D-67E2-4023-9AD5-C91908F1A31DQ33337922-C39C8C4D-ADB4-4EF4-A4C5-161FC60986CBQ33405128-2DB280B5-E263-462E-A898-DC841056406CQ33735917-C94EEFC1-6ABF-4B08-9A12-827A193DC518Q33805683-F02004EC-3C3E-4E2D-BB03-1F0686A5889BQ34079475-13D69D07-DB87-4948-AD9A-951CEBDD5F4AQ34697502-81006A06-4626-4026-A127-460573AB7A1AQ35110851-AC403F14-126C-4940-8A19-0A25264B64C8Q35772832-1C0AB5EC-D525-43B9-AF49-F3D75D75D318Q36016775-EEF51A0A-F169-433C-99A6-88E1F76E7CC9Q36776027-21E2502C-6916-4C37-8413-94AAFD410DD5Q36796911-6B35473D-5508-4B2B-97F1-7E91C0AF1B98Q38260285-9559F535-0405-4F88-8221-F412D43D8182Q54411025-B05C72A1-CF78-4A3F-8A1E-390DC3692EF6
P2860
CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
CREM deficiency in mice alters ...... parathyroid hormone treatment.
@ast
CREM deficiency in mice alters ...... parathyroid hormone treatment.
@en
type
label
CREM deficiency in mice alters ...... parathyroid hormone treatment.
@ast
CREM deficiency in mice alters ...... parathyroid hormone treatment.
@en
prefLabel
CREM deficiency in mice alters ...... parathyroid hormone treatment.
@ast
CREM deficiency in mice alters ...... parathyroid hormone treatment.
@en
P2093
P2860
P1433
P1476
CREM deficiency in mice alters ...... parathyroid hormone treatment.
@en
P2093
Barbara E Kream
Douglas J Adams
Sun-Kyeong Lee
P2860
P304
P356
10.1016/J.BONE.2006.12.003
P577
2007-02-01T00:00:00Z